Semaglutide is the active ingredient in Wegovy and Ozempic. How does this GLP-1 medication affect hunger, and does seeing “semaglutide” on a label mean the product is FDA-approved? This short explainer looks at how semaglutide acts on appetite signals in the brain and why you may feel less hungry. It also explains what the drug name tells you about a product and why FDA approval applies to the specific medicine. Chapters 00:00 Semaglutide, Wegovy and Ozempic: How appetite changes 00:21 Is every semaglutide product FDA-approved? 00:31 Rehealthify closing and medical disclaimer For more clear, evidence-based health information without the hype, subscribe to Rehealthify. Medical Disclaimer: This content is for educational and informational purposes only and is not medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding your health, medications, and treatment decisions. Do not start, stop, or adjust any medication based solely on this video. Sources & References U.S. Food and Drug Administration — Wegovy prescribing information, Section 12: Clinical Pharmacology https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218316Orig1s000lbl.pdf U.S. Food and Drug Administration — FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss #semaglutide #wegovy #ozempic #glp1